deltatrials
Completed PHASE1 NCT00001431

A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas

Sponsor: National Cancer Institute (NCI)

Conditions Gastrointestinal Neoplasms Pancreatic Neoplasms
Interventions gemcitabine
Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: Feb 28, 1995 Completion: Nov 30, 2000

This PHASE1 trial investigates Gastrointestinal Neoplasms and Pancreatic Neoplasms and is currently completed. National Cancer Institute (NCI) leads this study, which shows 5 recorded versions since 1995 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Feb 1995

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bethesda, United States